Patents expiring in 2038

EP 3283521

ARZNEIMITTELKONJUGATE MIT ANTIKÖRPERN GEGEN MIT CLAUDIN 18.2

GANYMED PHARMACEUTICALS GMBH [DE] · Granted Wed Feb 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Feb 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2018051034

KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION

4SC AG [DE] · Granted Thu Feb 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901638

Composition and method for treating an autoimmune disease

RedHill Biopharma Ltd. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902781

Antibodies for botulinum neurotoxins

The Regents of the University of California · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902690

Ethoxylated surfactants

The Board of Regents of the University of Oklahoma · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901546

Orally disintegrable tablets

Takeda Pharmaceutical Company Limited · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9903855

Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS

The Regents of the University of California · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901083

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901082

Genetically modified non-human animals and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901580

Methods of eye treatment using therapeutic compositions containing dipyridamole

O.D. Ocular Discovery Ltd. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902955

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902780

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902769

Treatment of dermatological pathologies

XBIOTECH INC. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902713

Neuroprotective compounds and use thereof

The Board of Regents of the University of Texas System · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902734

Nicotinic acetylcholine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902712

Nitrogenous heterocyclic derivatives and their application in drugs

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9902703

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901648

Stabilization of biomolecules using sugar polymers

The Regents of the University of California · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901606

Euglena lysate composition

ALGAEON, INC. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9901619

Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3034568

PROCEDE DE PREVENTION D'ATTAQUES AIGUES D'OEDEME DE QUINCKE HEREDITAIRE ASSOCIEES A UNE DEFICIENCE EN INHIBITEUR DE C1 ESTERASE

CSL BEHRING GMBH [DE] · Granted Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907820

Polyclonal gamma delta T cells for immunotherapy

The Board of Regents of the University of Texas System · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908878

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908899

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907807

Topical pharmaceutical compositions

Almirall, S.A. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908841

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9909188

Methods and compositions involving lincRNA and leukemia

The Regents of the University of California · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9909124

Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile

Ionis Pharmaceuticals, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9910031

Compositions and methods for modulating c-Rel-dependent cytokine production

Madrigal Pharmaceuticals, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907789

Sustained-release preparation

Takeda Pharmaceutical Company Limited · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908916

Peptide for suppressing osteoclast differentiation and use thereof

CAREGEN CO., LTD. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9909122

Compositions and methods of nucleic acid-targeting nucleic acids

Caribou Biosciences, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908970

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907762

Stabilized mutant opsin proteins

Regents of the University of Minnesota · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908879

P2X3 and/or P2X2/3 compounds and methods

Asana BioSciences, LLC · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907834

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9908856

Therapeutic compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907855

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907856

Carboxymethylcellulose-peptide conjugates and methods for using the same

The Regents of the University of California · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907796

Methods of treating tumoral diseases, or bacterial or viral infections

Inhibikase Therapeutics, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907803

Methods for treating attention deficit hyperactivity disorder

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907788

Inhibition of crystal growth of roflumilast

Arcutis, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907747

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9907479

Contribution of oxidative stress to AF electrograms

Northwestern University · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9914940

Targeted integration into the PPP1R12C locus

Sangamo Therapeutics, Inc. · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9915668

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9913892

Materials and methods for respiratory disease control in canines

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9913909

Compositions of a polyorthoester and an aprotic solvent

Heron Therapeutics, Inc. · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)